Sanders Jamie, Pallotta Andrea, Bauer Seth, Sekeres Jennifer, Davis Ramona, Taege Alan, Neuner Elizabeth
Department of Pharmacy, SoutheastHEALTH, Cape Girardeau, Missouri.
Infect Control Hosp Epidemiol. 2014 Mar;35(3):272-7. doi: 10.1086/675287. Epub 2014 Jan 29.
Evaluate antimicrobial stewardship interventions targeted to reduce highly active antiretroviral therapy (HAART)- or opportunistic infection (OI)-related medication errors and increase error resolution.
Retrospective before-after study.
Academic medical center.
Inpatients who were prescribed antiretroviral therapy before the intervention (January 1, 2011, to October 31, 2011) and after the intervention (July 1, 2012, to December 31, 2012). Patients treated with lamivudine or tenofovir monotherapy for hepatitis B were excluded.
Antimicrobial stewardship interventions included education, modification of electronic medication records, collaboration with the infectious diseases (ID) department, and prospective audit and review of HAART and OI regimens by an ID clinical pharmacist.
Data for 162 admissions from the preintervention period and 110 admissions from the postintervention period were included. The number of admissions with a medication error was significantly reduced after the intervention (81 [50%] of 162 admissions vs 37 (34%) of 110 admissions; P < .00)1. A total of 124 errors occurred in the preintervention group (mean no. of errors, 1.5 per admission), and 43 errors occurred in the postintervention group (mean no. of errors, 1.2 per admission). The most common error types were major drug interactions and dosing in the preintervention group and renal adjustment and OI-related errors in the postintervention group. A significantly higher error resolution rate was observed in the postintervention group (36% vs 74%; P < .001). After adjustment for potential confounders with logistic regression, admission in the postintervention group was independently associated with fewer medication errors (odds ratio, 0.4 [95% confidence interval, 0.24-0.77]; P = .005). Overall, presence of an ID consultant demonstrated a higher error resolution rate (32% without a consultation vs 68% with a consultation; P = .002).
Multifaceted, multidisciplinary stewardship efforts reduced the rate and increased the overall resolution of HAART-related medication errors.
评估旨在减少与高效抗逆转录病毒治疗(HAART)或机会性感染(OI)相关用药错误并提高错误解决率的抗菌药物管理干预措施。
干预前后回顾性研究。
学术医疗中心。
干预前(2011年1月1日至2011年10月31日)和干预后(2012年7月1日至2012年12月31日)接受抗逆转录病毒治疗的住院患者。排除接受拉米夫定或替诺福韦单药治疗乙型肝炎的患者。
抗菌药物管理干预措施包括教育、修改电子用药记录、与传染病(ID)科协作,以及由ID临床药师对HAART和OI治疗方案进行前瞻性审核和审查。
纳入了干预前期162例入院患者的数据和干预后期110例入院患者的数据。干预后用药错误的入院患者数量显著减少(162例入院患者中有81例[50%],而110例入院患者中有37例[34%];P <.001)。干预前组共发生124例错误(平均每例入院错误数为1.5),干预后组发生43例错误(平均每例入院错误数为1.2)。最常见的错误类型在干预前组是主要药物相互作用和剂量问题,在干预后组是肾脏调整和OI相关错误。干预后组的错误解决率显著更高(36%对74%;P <.001)。在通过逻辑回归对潜在混杂因素进行调整后,干预后组的入院与较少的用药错误独立相关(比值比,0.4[95%置信区间,0.24 - 0.77];P =.)。总体而言,有ID顾问参与显示出更高的错误解决率(无会诊时为32%,有会诊时为68%;P =.002)。
多方面、多学科的管理努力降低了HAART相关用药错误的发生率并提高了总体解决率。